Cosmetic method for enhancing antioxidant action of photoresponsive antioxidant

The cosmetic method enhances the antioxidant effects of photoresponsive compounds like riboflavin and others by exposing them to light, effectively addressing skin damage from UV radiation and improving skin health.

WO2024232264A1PCT designated stage expired Publication Date: 2024-11-14SHISEIDO CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/015993
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-08
Filing Date
2024-04-24
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Current antioxidants in cosmetics do not effectively enhance their antioxidant effects when exposed to light, particularly in the presence of ultraviolet radiation, which can lead to skin damage such as photoaging, wrinkles, and age spots.

Method used

A cosmetic method utilizing photoresponsive antioxidants like riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, combined with t-butylmethoxydibenzoylmethane, which are applied to the skin and then exposed to light, specifically visible or white light, to enhance their antioxidant properties.

Benefits of technology

The method significantly increases the antioxidant effect of these compounds, reducing active oxygen and lipid peroxides on the skin, thereby mitigating skin damage caused by UV exposure and promoting healthier skin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024015993_14112024_PF_FP_ABST
    Figure JP2024015993_14112024_PF_FP_ABST
Patent Text Reader

Abstract

The purpose of the present invention is to provide a cosmetic method with enhanced antioxidant action and a topical skin composition. The present invention is based on the finding that the antioxidant action of a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin is enhanced by light. Thus, provided is a cosmetic method for enhancing the antioxidant action of a photoresponsive antioxidant, the method comprising applying a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin to the skin, and then after application placing the skin in the presence of light.
Need to check novelty before this filing date? Find Prior Art

Description

Cosmetic method for enhancing the antioxidant effect of a photoresponsive antioxidant

[0001] The present invention relates to a cosmetic method for enhancing antioxidant activity, which comprises applying a photoresponsive antioxidant and placing it in the presence of light, and to a composition for topical application to the skin, which comprises a photoresponsive antioxidant.

[0002] Natural light is broadly divided into ultraviolet light, visible light, and infrared light. Ultraviolet light is known to have adverse effects on the skin, such as skin cancer, photoaging, age spots, wrinkles, and inflammation, and is undesirable from the perspectives of health and beauty. Many measures have been taken to protect the skin from ultraviolet light. Examples include the use of sunscreen, indoor activities to avoid sun exposure, UV-blocking hats and clothing, and the use of UV-blocking film.

[0003] Ultraviolet rays generate reactive oxygen species, which can have various physiological effects (Non-Patent Document 1). Reactive oxygen species are also generated by cellular activity in the body. The generated reactive oxygen species have various adverse effects, including cell carcinogenesis and aging. In the epidermis, the presence of reactive oxygen species activates melanocytes, promoting melanin production and causing age spots. In the dermis, activation of matrix metalloproteinases causes the breakdown of elastic fibers, leading to wrinkles and sagging. Reactive oxygen species also act on the genomic DNA of cells, potentially causing mutations. To suppress the generation and effects of reactive oxygen species, various antioxidants are incorporated into topical skin preparations, such as cosmetics. Examples of antioxidant ingredients incorporated into cosmetics include vitamin C, vitamin E, glutathione, and astaxanthin. Furthermore, extracts such as mast tree extract, Michaelmas extract, and winged bean extract have been selected for incorporation into cosmetics for their antioxidant effects (Patent Document 1: JP 2011-037764 A, JP 2012-144446 A, JP 2013-194020 A).

[0004] JP 2011-037764 A JP 2012-144446 A JP 2013-194020 A

[0005] Inflammation vol. 20, No. 2 March 2000 119 - 129

[0006] An object of the present invention is to obtain a light-responsive antioxidant whose antioxidant activity is enhanced by light.

[0007] The present inventors conducted screening to identify components with antioxidant activity whose antioxidant activity is enhanced by light. They discovered that riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin are components whose antioxidant activity can be enhanced by light, leading to the present invention. Furthermore, the present inventors discovered that the antioxidant activity enhanced by light can be further enhanced by further blending a photoresponsive antioxidant with t-butyl methoxydibenzoylmethane. Therefore, the present application provides the following invention: [1] A cosmetic method for enhancing the antioxidant activity of a photoresponsive antioxidant, comprising applying to skin a topical skin composition containing at least one photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, and then exposing the applied skin to light. [1-2] Use of at least one photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin for the manufacture of a topical skin composition for enhancing antioxidant activity, wherein the topical skin composition, instructions, packaging, and advertisements describe placing the skin in the presence of light after application. [2] The cosmetic method according to item 1, wherein the topical skin composition further comprises t-butyl methoxydibenzoylmethane. [3] The cosmetic method according to item 2, wherein the photoresponsive antioxidant is riboflavin. [4] The cosmetic method according to any one of items 1 to 3, wherein the topical skin composition further comprises a wavelength converting substance. [5] A topical skin composition comprising a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, and t-butyl methoxydibenzoylmethane as an antioxidant activity enhancer. [6] The topical composition for skin according to item 5, wherein the antioxidant enhancer enhances the antioxidant effect of the photoresponsive antioxidant in the presence of light. [7] The topical composition for skin according to item 5 or 6, which is contained in a light-shielding container. [8] The topical composition for skin according to any one of items 5 to 7, wherein the photoresponsive antioxidant is riboflavin.[9] The topical skin composition according to any one of items 5 to 9, further comprising a wavelength converting substance.

[10] Use of t-butyl methoxydibenzoylmethane in the manufacture of a topical skin composition containing a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, for enhancing the antioxidant effect of the photoresponsive antioxidant in the presence of light.

[0008] In the present invention, the antioxidant effect is enhanced by placing the skin in the presence of light after application of the photoresponsive antioxidant.

[0009] Figure 1 shows the IC of the photoresponsive antioxidant when it is placed under no light (Dark), visible light (VL), and white light (WL). 50 Figure 2 shows the change in antioxidant activity when riboflavin, a photoresponsive antioxidant, is combined with a candidate component of an antioxidant activity enhancer (t-butyl methoxydibenzoylmethane).

[0010] The present invention relates to a cosmetic method for enhancing antioxidant activity, which comprises applying a topical skin composition containing a photoresponsive antioxidant and placing it in the presence of light.An antioxidant whose antioxidant activity is enhanced in the presence of light is referred to as a photoresponsive antioxidant.

[0011] In the present invention, the photoresponsive antioxidant is at least one selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin. Cosmetically or pharmaceutically acceptable salts of these photoresponsive antioxidants may also be used as the photoresponsive antioxidant. For example, sodium salts, potassium salts, calcium salts, ammonium salts, etc. of caffeic acid or ferulic acid may be used.

[0012] In the present invention, the antioxidant activity of skin to which a topical skin composition containing a photoresponsive antioxidant has been applied is enhanced by exposing the skin to light. The light may be visible light alone, white light including ultraviolet light, or natural light, and light that enhances the antioxidant activity of the photoresponsive antioxidant can be appropriately selected. Exposing the skin to light may involve exposure to electric light or sunlight in everyday life, or irradiation with light using an irradiator. The cosmetic method of the present invention may include irradiating the skin with visible light of a specific wavelength after application of a topical skin composition containing a photoresponsive antioxidant, thereby enhancing the antioxidant activity of the applied topical skin composition. The cosmetic method of the present invention may be performed, for example, at a beauty salon or other facility by a cosmetic practitioner other than a physician using an irradiator capable of irradiating visible light of a specific wavelength. Therefore, the cosmetic method of the present invention is clearly distinguished from a therapeutic method and can also be considered a non-therapeutic method. The packaging, product instructions, and advertisements for products containing the topical skin composition of the present invention may state that the product should be placed in the presence of light after application.

[0013] The cosmetic method and topical skin composition of the present invention enhance the antioxidant effect in the skin, thereby reducing the reactive oxygen species and lipid peroxides generated in the skin. Therefore, the cosmetic method and topical skin composition of the present invention are preferably applied to skin in which reactive oxygen species and lipid peroxides are particularly increased, such as skin after sunburn or mental stress. Furthermore, the reactive oxygen species and / or lipid peroxides accumulated in the skin during daily life can be reduced.

[0014] In one embodiment, the topical composition for skin according to the present invention is applied to the skin, and light to be irradiated is selected according to the photoresponsive antioxidant contained in the topical composition for skin, and the composition can be irradiated using a light irradiator. The irradiation intensity and irradiation time can be appropriately selected depending on the light irradiator, and as an example, an integrated light dose of 20 to 80 J / cm is used. 2 It is preferable to irradiate the photosensitive material with light of 30 J / cm depending on the type of photoresponsive antioxidant. 2 Above, 40J / cm 2 or more may be used, and 70 J / cm 2 Less than 60 J / cm2 A light irradiator of less than 1000 kJ / hour may be used. The light irradiator may be a handheld type or may be for whole-body irradiation, so as to irradiate only the skin to which the topical skin composition has been applied. The topical skin composition may be applied to the skin of the whole body, but may also be applied to any part of the body, such as the face, limbs, or body, particularly from the viewpoint of exerting an antioxidant effect.

[0015] In the present invention, the light to be irradiated can be appropriately selected depending on the degree of enhancement of antioxidant activity. When riboflavin is used as the photoresponsive antioxidant, riboflavin is inactive without light exposure, and its antioxidant activity is significantly enhanced under white light compared to visible light (Figure 1). Therefore, it is preferable to irradiate white light using a light irradiator that generates white light. When caffeic acid, ferulic acid, or a salt thereof is used as the photoresponsive antioxidant, both visible light and white light enhance the antioxidant activity, but the antioxidant activity is more enhanced in the presence of white light (Figure 1). Therefore, white light can be irradiated using a light irradiator that generates white light. However, since these photoresponsive antioxidants can sufficiently enhance the antioxidant activity even with visible light, visible light may also be irradiated to avoid exposure to ultraviolet light contained in white light. On the other hand, when resveratrol and honokiol are used, the antioxidant activity is more enhanced under visible light than under white light. Therefore, when these photoresponsive antioxidants are used, it is preferable to irradiate with visible light. Since quercetin, fisetin, and myricetin each have the same antioxidant activity promoting effect under both visible light and white light, either type of light may be used, but it is preferable to irradiate with visible light in order to avoid irradiation with ultraviolet light contained in white light.As described above, it is preferable to select a light source that greatly enhances antioxidant activity depending on the type of photoresponsive antioxidant.In addition, when combined with a wavelength conversion substance that converts ultraviolet light to visible light, the visible light emitted by the wavelength conversion substance is enhanced, thereby enhancing the antioxidant activity.

[0016] Visible light refers to light having more than 80%, preferably more than 85%, of its light energy in the wavelength range of 400 nm to 760 nm. Typically, UV light can be irradiated by attaching a UV filter that blocks UV rays to a solar simulator or the like, or by using a light source that has been designed to suppress UV generation in advance. White light refers to light that contains UV rays with wavelengths of 400 nm or less, visible light with wavelengths of 400 to 760 nm, and infrared rays with wavelengths of 800 nm or more, and does not have a significant bias in the energy balance of each. White light may be natural light, or it can be irradiated using a light source that simulates natural light, such as a solar simulator, without a filter. UV light is light with a wavelength in the range of 200 to 400 nm, and can be irradiated by applying a film that transmits only UV rays to a UV generator or a light source that simulates natural light.

[0017] Another aspect of the present invention may relate to a topical skin composition containing a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin. Such a topical skin composition is characterized in that the skin is placed in the presence of light after application. Such usage instructions are clearly stated on product packaging, advertisements, etc. The topical skin composition of the present invention may further contain t-butyl methoxydibenzoylmethane as an antioxidant enhancer. The topical skin composition of the present invention may further contain a wavelength conversion substance. This allows the ultraviolet light to be converted into visible light, which acts on the photoresponsive antioxidant and exerts its antioxidant effect, even when the topical skin composition applied to the skin is exposed to ultraviolet light outdoors, etc. As a more specific example, the present invention may relate to a topical skin composition containing riboflavin and t-butyl methoxydibenzoylmethane as an agent that enhances the antioxidant effect of riboflavin. Riboflavin can be blended at 0.00001 to 1%, and t-butyl methoxydibenzoylmethane as an antioxidant enhancer can be blended at 0.01 to 5%.

[0018] In yet another aspect, the present invention may relate to an agent for enhancing the activity of a photoresponsive antioxidant, comprising t-butyl methoxydibenzoylmethane. Examples of photoresponsive antioxidants whose antioxidant activity can be enhanced by incorporating t-butyl methoxydibenzoylmethane include photoresponsive antioxidants selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, and particularly riboflavin. In yet another aspect, the present invention may relate to a method for enhancing the antioxidant activity of a photoresponsive antioxidant, comprising incorporating t-butyl methoxydibenzoylmethane.

[0019] Yet another aspect of the present invention may relate to the use of t-butyl methoxydibenzoylmethane in the preparation of a topical skin composition containing a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, for enhancing the antioxidant activity of the photoresponsive antioxidant in the presence of light. The use of t-butyl methoxydibenzoylmethane in the preparation of such a topical skin composition can enhance the antioxidant activity of the photoresponsive antioxidant.

[0020] In the present invention, antioxidant activity can be measured using any indicator. As an example, the antioxidant activity of a candidate component can be determined using a DPPH assay. The DPPH assay is performed by adding a candidate component to a solution containing 2,2-diphenyl-1-picrylhydrazyl (DPPH). The DPPH solution exhibits a blue color in the free radical state and, when reduced in the presence of a photoresponsive antioxidant, exhibits a pale yellow color. This color change can be determined based on the absorbance at a wavelength of 517 nm. In the non-reduced state (i.e., oxidized state), the absorbance at 517 nm is high, while in the reduced state, the absorbance at 517 nm decreases. Therefore, the antioxidant activity of a candidate component can be determined by preparing a blue DPPH solution, adding the candidate component, and measuring the change in absorbance (Anal Sci 2018;34(7):795-800. doi: 10.2116 / analsci.18P014.). Furthermore, in the present invention, in order to detect changes in antioxidant activity due to light irradiation, after adding a candidate ingredient, the samples were divided into a non-irradiated group, a UV light-irradiated group, a visible light-irradiated group, and a white light-irradiated group, and the non-irradiated group was stored in a dark place for a predetermined period of time. The light-irradiated group was irradiated with each light for 10 minutes, and the absorbance was measured a predetermined period after irradiation, thereby determining the antioxidant activity of the candidate ingredient. As an example, the absorbance can be measured 15 minutes and 30 minutes after light irradiation.

[0021] In the present invention, a wavelength converting material refers to a material that absorbs incident light of a specific wavelength and emits outgoing light of a longer wavelength than the incident light. The incident light absorbed by the wavelength converting material of the present invention is preferably ultraviolet light. The outgoing light emitted by the wavelength converting material has a wavelength longer than that of ultraviolet light, preferably having a peak wavelength of 450 nm to 700 nm, more preferably 500 nm to 700 nm. In an embodiment, the wavelength converting material emits light with a dominant wavelength of 450 nm to 700 nm, more preferably 500 nm to 700 nm, when excited with excitation light of 200 nm to 400 nm.

[0022] Examples of wavelength converting substances include the following components: phycobiliproteins such as allophycocyanin, C-phycocyanin, R-phycocyanin, phycoerythrocyanin, B-phycoerythrin, b-phycoerythrin, C-phycoerythrin, and R-phycoerythrin; naturally occurring or synthetic components such as vitamin A, vitamin K, vitamin B1, vitamin B6, vitamin B12, folic acid, niacin, gardenia, safflower, turmeric, cochineal, perilla, red cabbage, flavonoids, carotenoids such as β-carotene and lycopene, quinoids, porphyrins, anthocyanins, and polyphenols; Red No. 401, Red No. 227, Red No. 504, Red No. 218, Orange No. 205P, Yellow No. 4, Yellow No. 5, Green No. 201, pyranine concentrate, and Blue No. 1. Examples of suitable phosphors include dyes such as 2,4-diaminophenoxyethanol hydrochloride, Alizurin Purple SS, Purple No. 401, Black No. 401, Herringdon Pink, Yellow No. 401, Benzidine Yellow G, Blue No. 404, Red No. 104, and meta-aminophenol; phosphors obtained by doping inorganic compounds to give them fluorescence, such as the blue phosphor described in Japanese Patent No. 6424656 containing amorphous silica particles, cerium, phosphorus, and / or magnesium, and the red phosphor described in Japanese Patent No. 6361416 containing a compound obtained by activating a mixed crystal of an alkaline earth metal sulfide and a gallium compound with europium, the zinc oxide phosphor described in International Publication No. 2018 / 004006, and the zinc oxide phosphor described in Japanese Patent Application Laid-Open No. 2018-131422; and the inorganic phosphor described in Japanese Patent Application Laid-Open No. 5-117127. In one embodiment, the inorganic phosphor is ZnO:Zn, Zn 1+z , ZnO 1-x and doped with a sulfur-containing compound, such as a sulfide salt and / or sulfate, as described in WO 2018 / 004006; magnesium titanate phosphors obtained by doping magnesium titanate, such as MgTiO3 and Mg2TiO4, with manganese; and calcium phosphate phosphors obtained by doping calcium phosphate, such as Ca(H2PO4)2, CaHPO4, and Ca3(PO4)2, with cerium.

[0023] Wavelength conversion substances may be obtained by extraction from natural sources such as animals, plants, and algae, or by artificial methods such as chemical synthesis. For example, phycobiliproteins may be prepared by extracting algae such as blue-green algae (Spirulina platensis) or red algae (Porphyridium purpureum) using methods described in, for example, Japanese Patent Nos. 4048420, 4677250, and 3303942. Zinc oxide phosphors may be produced using methods described in, for example, International Publication No. 2018 / 004006, Japanese Patent Application Publication No. 2018-131422, and Japanese Patent Application Publication No. 5-117127. Magnesium titanate phosphors may be produced using methods described in Japanese Patent Application Publication No. 2017-88719. Calcium phosphate phosphors may be produced using methods described in International Publication No. 2018 / 117117. Among these, from the viewpoint of application to a composition for external use on the skin, a substance selected from the group consisting of zinc oxide fluorescent substance, magnesium titanate fluorescent substance, and C-phycocyanin can be used as the wavelength conversion substance.

[0024] The topical skin composition of the present invention may be any topical skin composition containing the photoresponsive antioxidant specified in the present invention. Such topical skin compositions may be pharmaceuticals, quasi-drugs, cosmetics, etc. The formulation, application method, and number of administrations of the topical skin preparation used in the cosmetic method of the present invention can be determined as desired. For example, the topical skin composition may be in the form of a lotion, spray, oil, cream, emulsion, gel, sunscreen, or tanning agent. Prior to light irradiation in the cosmetic method of the present invention, the topical skin composition may be applied once or multiple times, and then light irradiation may be performed immediately or after a certain period of time, for example, 10 minutes to several hours. Instead of light irradiation, light irradiation may be performed by being active outdoors or indoors with the lights on. The topical skin composition of the present invention may be stored in a light-shielding container. The photoresponsive antioxidant contained in the topical skin composition of the present invention exhibits increased antioxidant activity upon light irradiation, but light irradiation may also cause the photoresponsive antioxidant to lose its stability. Therefore, storing the composition in a light-shielding container allows the photoresponsive antioxidant to be maintained stably until immediately before application.

[0025] Riboflavin, also known as vitamin B2, is known to contribute to the metabolism of fats, carbohydrates, and proteins, as well as respiration and red blood cell formation in the body. Riboflavin is essential for maintaining healthy skin, nails, hair, and other skin conditions. A deficiency can lead to symptoms such as stomatitis, dermatitis, keratitis, hair loss, and red blood cells. Riboflavin can be incorporated into cosmetics and pharmaceuticals to maintain normal skin function. Riboflavin's effects on skin have been shown to suppress the mRNA expression of UV-induced inflammatory cytokines (IL-1α, GM-CSF) (Non-Patent Document 1: PLoS One. 2016 Sep 20;11(9):e0161580. doi: 10.1371). The same document also showed that riboflavin's effects on skin include suppressing the mRNA expression of UV-induced MMP1, while not altering MMP1 protein levels.

[0026] Caffeic acid has the following formula: Caffeic acid is an aromatic carboxylic acid having the formula (I), and may be in the form of a salt acceptable for pharmaceuticals or cosmetics. Caffeic acid is a type of polyphenol contained in coffee, and has antioxidant properties as well as anti-inflammatory and liver function improving effects. Caffeic acid is blended in cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, and more preferably 0.001 to 0.5%.

[0027] Ferulic acid has the following formula: and may be in the form of a salt acceptable for pharmaceuticals or cosmetics. Ferulic acid is a type of polyphenol that constitutes lignin, and has been reported to have antioxidant activity as well as antitumor activity against breast cancer, liver cancer, and the like. Ferulic acid is blended into cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, and more preferably 0.001 to 0.5%.

[0028] Resveratrol has the following formula: Resveratrol is a type of stilbene derivative polyphenol having the formula: [Resveratrol is known as an antioxidant found in grape skin.] Research is being conducted into its physiological effects, such as preventing arteriosclerosis and obesity, and extending lifespan through activation of sirtuins. Resveratrol is incorporated into cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, with 0.001% to 0.5% being more preferred.

[0029] Honokiol has the following formula: Honokiol is a compound represented by the formula: Honokiol is a type of polyphenol found in the bark of the magnolia tree and has antioxidant properties. Honokiol is used as a traditional Chinese medicine and has been reported to have physiological effects such as analgesic, anti-inflammatory, and anti-cancer properties. Honokiol is blended into cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, with 0.001% to 0.5% being more preferred.

[0030] Myricetin has the following formula: Myricetin is a compound represented by the formula: Myricetin is a type of flavonoid found in grapes, berries, etc., and has antioxidant properties. Myricetin is blended into cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, with 0.001% to 0.5% being more preferred.

[0031] Quercetin has the following formula: Quercetin is a compound represented by the formula: Quercetin is a type of flavonoid found in citrus fruits, onions, and buckwheat, and has been reported to have antioxidant, anti-inflammatory, and anti-arteriosclerotic effects. Quercetin is blended into cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, and more preferably 0.001 to 0.5%.

[0032] Fisetin has the formula: Fisetin is a compound represented by the formula: Fisetin is a type of flavonoid found in strawberries, cognac trees, etc., and has been reported to have antioxidant properties as well as anti-inflammatory, anti-cancer, and anti-aging properties. Fisetin is blended into cosmetics, quasi-drugs, or pharmaceuticals at a concentration of 0.00001 to 1%, and more preferably 0.001 to 0.5%.

[0033] t-Butyl methoxydibenzoylmethane can be applied to the skin in combination with the photoresponsive antioxidant of the present invention, further enhancing the antioxidant activity of the photoresponsive antioxidant, particularly riboflavin, in the presence of light.

[0034] In order to exert the physiological effects exerted by the photoresponsive antioxidant of the present invention, an external skin composition containing an extract containing the photoresponsive antioxidant may be used instead of the photoresponsive antioxidant. Examples of extracts containing riboflavin include yeast extract, mushroom extract, meat extract, fish extract, and cod liver oil. Examples of extracts containing caffeic acid include coffee beans. Examples of extracts containing ferulic acid include rice bran extract. Examples of extracts containing resveratrol include grape extract. Examples of extracts containing honokiol include magnolia extract.

[0035] The extracts described herein can be obtained by conventional methods, for example, by immersing or refluxing the plant material with an extraction solvent at room temperature or elevated temperatures, followed by filtration and concentration. Any solvent commonly used for extraction can be used as the extraction solvent. For example, aqueous solvents such as water, physiological saline, phosphate buffer, borate buffer, or organic solvents such as alcohols (e.g., ethanol, propylene glycol, 1,3-butylene glycol, glycerin), hydrous alcohols, chloroform, dichloroethane, carbon tetrachloride, acetone, ethyl acetate, hexane, etc., can be used alone or in combination. A mixed solvent of water and an alcohol (e.g., 1,3-butylene glycol) is preferably used. The extract obtained by extraction with the above solvents can be used directly or after concentration by, for example, freeze-drying. If necessary, the extract can be used after removing impurities using an adsorption method, such as an ion exchange resin, or after adsorption on a porous polymer (e.g., Amberlite XAD-2) column, followed by elution with a desired solvent and further concentration.

[0036] The topical skin composition of the present invention may contain, as needed, any additives selected and used in combination, such as excipients, preservatives, thickeners, binders, disintegrants, dispersants, stabilizers, gelling agents, antioxidants, surfactants, preservatives, oils, powders, water, alcohols, thickeners, chelating agents, silicones, antioxidants, moisturizers, fragrances, various medicinal ingredients, antiseptics, pH adjusters, neutralizers, etc. Furthermore, other cell activators and the like may be used in combination to enhance the effects of the present invention.

[0037] In a further aspect, the present invention may relate to a beauty kit comprising an external skin composition containing riboflavin and an irradiator that irradiates visible light at 1,000 to 10,000 Lux with a wavelength in the visible light range, particularly a wavelength of 450 to 700 nm, 450 to 600 nm, or 500 to 550 nm. Such a beauty kit may be used by a purchaser or a beauty practitioner. The irradiator that irradiates visible light can be any irradiator known in the art. From the viewpoint of irradiating visible light in a predetermined peak range, it is preferable to use an LED.

[0038] The present invention will now be described in more detail with reference to examples, although the present invention is not limited thereto.

[0039] Example 1: Evaluation of antioxidant activity by DPPH assay. 100 μL of solutions of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, and fisetin at concentrations of 0.001%, 0.01%, and 0.05% as photoresponsive antioxidants were dispensed into wells of a 96-well plate. 100 μL of Trolox was dispensed into wells as a control photoresponsive antioxidant. After addition of the photoresponsive antioxidants, the wells were irradiated for 1 minute using a solar simulator (91192-1000, Newport) under the following conditions: The intensity of the solar simulator was 50 J / cm, with an integrated irradiation dose of 50 J / cm from wavelengths of 400 nm to 800 nm. 2The visible light irradiation section was irradiated with visible light through a filter GG420 (SCHOTT). The white light irradiation section was irradiated with white light without using a filter. The non-irradiated section was not irradiated. Next, 100 μL of a 300 μmol / L methanol solution of 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) was added to the well. The absorbance of the irradiated section was measured 15 and 30 minutes after the addition of DPPH, and the absorbance of the non-irradiated section was measured 1, 15, and 30 minutes after the addition of DPPH. Based on the measured absorbance, the IC for each inhibitor was calculated. 50 The concentration (concentration that achieves 50% inhibition of DPPH radical) was measured, and the results are shown in Figure 1.

[0040] Riboflavin had no antioxidant activity in the dark (unexposed) area, making it impossible to calculate an IC50 value. On the other hand, a weak antioxidant activity was observed in the visible light-exposed area, while a strong antioxidant activity was observed in the white light-exposed area, demonstrating that light exposure enhanced the antioxidant activity. Honokiol, ferulic acid, caffeic acid, resveratrol, quercetin, fisetin, and myricetin each exhibited antioxidant activity in the unexposed area, but their antioxidant activity was enhanced by both visible and white light exposure. Quercetin, fisetin, honokiol, and resveratrol had stronger antioxidant activity in the visible light-exposed area than in the white light-exposed area. On the other hand, myricetin, ferulic acid, and caffeic acid had stronger antioxidant activity in the white light-exposed area than in the visible light-exposed area.

[0041] Example 2: Antioxidant Promoters Combined with Riboflavin 100 μL of 0.0001%, 0.001%, and 0.01% riboflavin solutions were dispensed into wells of a 96-well plate. As a control, 100 μL of 0.01% Trolox was dispensed into wells. In addition to the photoresponsive antioxidants, octyl salicylate, octosilylene, homosalate, and t-butyl methoxydibenzoylmethane (Parsol 1789) were added as candidate antioxidant promoters at concentrations of 0%, 0.5%, 1%, and 2.5%, respectively. After addition, the wells were irradiated with white light without a filter using a solar simulator (91192-1000, Newport). The intensity of the solar simulator was set to 50 J / cm², with an integrated irradiation dose from 400 nm to 800 nm. Next, 100 μL of a 300 μmol / L solution of 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) in methanol was added to the wells. For the illuminated compartment, absorbance was measured 30 minutes after the addition of DPPH. Based on the measured absorbance, the IC for each inhibitor was calculated. 50 The value (concentration that achieves 50% inhibition of DPPH radical) was measured. The results for t-butyl methoxydibenzoylmethane, which showed a dose-dependent increase in antioxidant activity, are shown in a graph. The results are shown in Figure 2.

[0042] Among the candidate components for promoting antioxidant activity, t-butyl methoxydibenzoylmethane was shown to enhance the antioxidant activity of riboflavin in a dose-dependent manner.

Claims

1. A cosmetic method for enhancing the antioxidant effect of a photoresponsive antioxidant, comprising applying to the skin a topical skin composition containing at least one photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, and placing the skin after application in the presence of light.

2. The cosmetic method according to claim 1, wherein the topical skin composition further contains t-butyl methoxydibenzoylmethane.

3. The cosmetic method according to claim 2, wherein the photoresponsive antioxidant is riboflavin.

4. The cosmetic method according to claim 1, wherein the topical skin composition further comprises a wavelength converting substance.

5. A composition for external application to the skin comprising a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, and t-butyl methoxydibenzoylmethane as an antioxidant enhancer.

6. The topical skin composition according to claim 5, wherein the antioxidant enhancer enhances the antioxidant effect of the photoresponsive antioxidant in the presence of light.

7. The composition for external application to skin according to claim 6, contained in a light-shielding container.

8. The topical skin composition according to claim 5, wherein the photoresponsive antioxidant is riboflavin.

9. The topical skin preparation according to claim 5, further comprising a wavelength converting substance.

10. Use of t-butyl methoxydibenzoylmethane in the manufacture of a skin topical composition containing a photoresponsive antioxidant selected from the group consisting of riboflavin, caffeic acid, ferulic acid, resveratrol, honokiol, myricetin, fisetin, and quercetin, for enhancing the antioxidant effect of the photoresponsive antioxidant in the presence of light.

Citation Information

Patent Citations

  • Beauty method to enhance physiological effects of riboflavin using visible light

    JP2024031642A

  • Cell activator

    WO2020204105A1